IDEAYA Biosciences, Inc. (FRA:30J)
Germany
· Delayed Price · Currency is EUR 29.40
+0.60 (2.08%)
Last updated: Dec 4, 2025, 8:05 AM CET
IDEAYA Biosciences Revenue
IDEAYA Biosciences had revenue of $207.83M USD in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $214.83M, up 5,377.66% year-over-year. In the year 2024, IDEAYA Biosciences had annual revenue of $7.00M, down -70.07%.
Revenue (ttm)
$214.83M
Revenue Growth
+5,377.66%
P/S Ratio
14.76
Revenue / Employee
$1.64M
Employees
131
Market Cap
2.70B EUR
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |